Publicação
Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025
| dc.contributor.author | Gaio, Vânia | |
| dc.contributor.author | Henriques, Camila | |
| dc.contributor.author | Lança, Miguel | |
| dc.contributor.author | Marques, Rita | |
| dc.contributor.author | Marques, Raquel | |
| dc.contributor.author | Rodrigues, Marta | |
| dc.contributor.author | Almeida, Sofia | |
| dc.contributor.author | Sousa, Beatriz | |
| dc.contributor.author | Freitas, Margarida | |
| dc.contributor.author | Amaral, Diana | |
| dc.contributor.author | Ferreira, Sara | |
| dc.contributor.author | Azevedo, Inês | |
| dc.contributor.author | von Hafe, Madalena | |
| dc.contributor.author | Gonçalves, Rafaela | |
| dc.contributor.author | Viseu, Regina | |
| dc.contributor.author | Bandeira, Teresa | |
| dc.contributor.author | Constant, Carolina | |
| dc.contributor.author | Malato, Madalena | |
| dc.contributor.author | Carvalho, Inês | |
| dc.contributor.author | Rodrigues, Jorge | |
| dc.contributor.author | Farinha, Margarida | |
| dc.contributor.author | Nunes, Teresa | |
| dc.contributor.author | Graça, Teresa | |
| dc.contributor.author | Gomez, Sofia | |
| dc.contributor.author | Soares, Sara | |
| dc.contributor.author | Neves, João Farela | |
| dc.contributor.author | Paixão, Paulo | |
| dc.contributor.author | Piscalho, Inês | |
| dc.contributor.author | Loureiro, Ana | |
| dc.contributor.author | Freitas, Cristina | |
| dc.contributor.author | Alves, José | |
| dc.contributor.author | Soares, Diana | |
| dc.contributor.author | Lopes, Paulo | |
| dc.contributor.author | Machado, Ausenda | |
| dc.contributor.author | Guiomar, Raquel | |
| dc.contributor.author | Rodrigues, Ana Paula | |
| dc.contributor.author | VigiRSV Group | |
| dc.date.accessioned | 2026-01-20T13:01:55Z | |
| dc.date.available | 2026-01-20T13:01:55Z | |
| dc.date.issued | 2025-11-30 | |
| dc.description | VigiRSV Group: Ana Carolina Pinto, Liliana Macedo, Paula Mota, Maria Francisca Santos, Carlota Ferreira, Elsa Melanie dos Santos, Ana Pinto, Tomás Tinoco, Natasha Rosário, Xavier Ferreira, Susana Maia, Inês Lopes, Vânia Soares, Arminda Jorge, Patrícia Ibarzabal, José Alves, Joana Leal, Inês Couto, Beatriz Lourenço, Cláudia Fernandes, Carolina Ferreira, Bruna Barbosa, Catarina Encarnação, Rosário Barreto, Ana Sofia Santos, Marisa Nunes, Raul Martins, Ana Dias Alves, Florbela Cunha, Carla Cruz, Nádia Cavaco e Pedro Fernandes da Gama, Elsa Rocha, Cláudia Calado, Bernardo Camacho, Andreia Afonso e Fátima Pestana, and Raquel Ferreira. | |
| dc.description.abstract | We assessed Nirsevimab effectiveness (NE) against respiratory syncytial virus (RSV)-related hospitalisation in eligible children (< 2 years) using a test-negative case-control design within the VigiRSV network (weeks 43/2024 to 16/2025). Among 341 participants (median age: 2 months; 91.2% without known chronic condition), 137 (40.2%) tested RSV-positive. Adjusted NE against RSV-related hospitalisation was 78.5% (95%CI: 59.3-89.0). Sensitivity analyses confirmed the robustness of the results. These findings support Nirsevimab's effect in a predominantly healthy infant population and contribute to informing public health decisions for RSV immunisation. | eng |
| dc.identifier.citation | Influenza Other Respir Viruses. 2025 Dec;19(12):e70186. doi: 10.1111/irv.70186. Epub 2025 Nov 30 | |
| dc.identifier.doi | 10.1111/irv.70186 | |
| dc.identifier.eissn | 1750-2659 | |
| dc.identifier.issn | 1750-2640 | |
| dc.identifier.pmid | 41320971 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/10722 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.publisher | Wiley | |
| dc.relation.hasversion | https://onlinelibrary.wiley.com/doi/10.1111/irv.70186 | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | RSV | |
| dc.subject | RSV‐Related Hospitalisations | |
| dc.subject | Children | |
| dc.subject | Effectiveness | |
| dc.subject | Nirsevimab | |
| dc.subject | Infecções Respiratórias | |
| dc.subject | Determinantes da Saúde e da Doença | |
| dc.subject | Observação em Saúde e Vigilância | |
| dc.subject | Cuidados de Saúde | |
| dc.subject | Portugal | |
| dc.title | Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025 | eng |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 12 | |
| oaire.citation.startPage | e70186 | |
| oaire.citation.title | Influenza and Other Respiratory Viruses | |
| oaire.citation.volume | 19 | |
| oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 |
